CSI Market
Sign In | Register

Zeo Scientifix Inc (BPSR) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access BPSR Annual Cash Flow →
The quarterly cash flow data below helps track how Zeo Scientifix Inc's liquidity profile has evolved over recent quarters.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Apr 30 2026)
6 Months 		(Jan 31 2026) (Oct 31 2025) (Jul 31 2025) (Apr 30 2025)
Operating Activities
Income-1.00
Depreciation & amortization0.04
Amortization of Other Assets0.00
Increase (Decrease) in Deferred Revenue0.07
Impairment of Long-Lived Assets Held-for-use0.00
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories-0.31
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment0.00
Share-based Compensation1.18
Income (Loss) from Equity Method Investments0.00
Financial Instruments and Foreign Currency Transaction0.00
Interest Expense Debt-
Original Issue Discount Convertible Note-
Settlement Of Executive Employment Obligations-
Gains Losses On Sales Of Assets-
Interest Expense On Conversion Of Funding Facility-
Amortization Of Oid And Commitment Fee Discount Promissory Note-
Stock Issued In Settlement Of Litigation-
Stocks Issued In Settlement Of Litigation-
Reserve For Bad Debt-
Amortization Of Oid Promissory Notes-
Amortization Of Oid And Commitment Fee Discount Promissory Notes0.00
Write Off Of Deferred Debt Issuance Cost-
Change In Obligation To Repurchase Shares0.00
Reserve Of Nonmarketable Securities Related Party-
Income taxes0.00
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts Receivable-0.24
Increase (Decrease) in Accounts Payable and Accrued Liabilities0.23
Increase (Decrease) in Accrued Liabilities0.00
Increase (Decrease) in Security Deposits-0.01
Increase (Decrease) in Prepaid Expense-0.18
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities-0.39
Discontinued operations0.00
Net Cash flow from Operating Activities-0.61
Investing Activities
Capital Expenditures-0.08
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Payments for Leasing Costs0.00
Investment In Nonmarketable Equity Securities-
Investment In Nonmarketable Equity Securities Related Party-
Proceeds From Sale Of Exotropin Interests0.38
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Proceeds from Sale of Other Assets, Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities0.30
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock1.95
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-0.24
Proceeds From Sale Of Common Stock And Warrants Minority Interest-
Proceeds From Sale Of Common Stock And Warrants-
Proceeds From Sale Of Common Stock And Warrants Noncontrolling Interest-
Capital Leases Contingent Rental Payments Received-
Finance Lease Principal Payments-
Payments On Finance Lease-0.01
Shares Repurchased In Connection With Litigation-
Advances For Future Stock Purchases-
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents0.22
Payments of Ordinary Dividends, Noncontrolling Interest0.01
Dividends paid0.00
Net Cash Flow from Financing Activities1.94
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-0.69
Total Cash Flow1.63
4 historic quarters locked

Sign in to unlock the full Zeo Scientifix Inc cash flow history.

Sign In Create Free Account

About Zeo Scientifix Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001829126-26-006486

Figures are derived from filed reports and may be restated. Historical data is subject to revision.